Monthly information on share capital and company voting rights

Cellectis has released its monthly update on share capital and voting rights as of May 31, 2024.

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Cellectis has released its monthly update on share capital and voting rights as of May 31, 2024. The company, listed on Euronext Growth with ISIN code FR0010425595, reports a total of 100,093,635 shares in its capital. The number of voting rights stands at 88,029,374. For more details, media and investor relations contacts are provided.

Positive

The company has a substantial number of shares, indicating a large capital base.
Maintaining regular updates on share capital and voting rights promotes transparency.

Negative

The voting rights are significantly lower than the total number of shares, potentially indicating diluted voting power for shareholders.

Argus Session date unavailable

-2.20% session move Open Argus

Details

News Market Reaction – CLLS

The recorded move for CLLS in the trading session of this news was -2.20%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

06/05/2024 - 04:30 PM

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, June 05, 2024 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
05/31/2024	100,093,635	88,029,374

For further information on Cellectis, please contact:    

Media contact:      

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contacts:      

Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com

Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577 

Attachment

Voting_Rights_PR_May 31st 2024_EN

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the total number of shares for Cellectis as of May 31, 2024?

The total number of shares for Cellectis as of May 31, 2024, is 100,093,635.

How many voting rights does Cellectis have as of May 31, 2024?

As of May 31, 2024, Cellectis has 88,029,374 voting rights.

On which market is Cellectis listed?

Cellectis is listed on Euronext Growth.

What is the ISIN code for Cellectis?

The ISIN code for Cellectis is FR0010425595.

Who can I contact for more information about Cellectis?

For more information, you can contact Pascalyne Wilson, Director of Communications, or Patricia Sosa Navarro, Chief of Staff to the CEO. Investor relations contacts include Arthur Stril and Ashley R. Robinson.

Keep reading

Trending in the feed

IONQ

IonQ to Acquire Elisity to Accelerate Zero Trust for the Quantum Era Open the live feed